Glenmark Pharmaceuticals Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	532296	NSE Symbol:	GLENMARK	P/E :	28.58
ISIN Demat:	INE935A01035	Div & Yield %:	0.13	EPS :	66.4
Book Value:	868.32	Market Cap (Rs. Cr.):	53,561.71	Face Value :	1

Date	Headline
26-Sep-25	Board of Glenmark Pharmaceuticals recommends interim dividend
24-Sep-25	Glenmark inks license and collaboration agreement with Hengrui Pharma
23-Sep-25	Glenmark Pharmaceuticals to conduct board meeting
19-Sep-25	Glenmark Pharmaceuticals receives affirmation in credit rating from CRISIL
15-Sep-25	Glenmark Pharma to transfer its consumer care biz to Glenmark Consumer Care
09-Sep-25	Ichnos Glenmark Innovation receives upfront payment of USD700 million
05-Sep-25	Glenmark Pharma initiates Phase 3 clinical trial for Envafolimab
02-Sep-25	Glenmark USA to launch Eribulin Mesylate Injection, mg/2 mL (0.5 mg/mL) Single-Dose Vials
23-Aug-25	Glenmark Pharmaceuticals to conduct AGM
19-Aug-25	Glenmark USA to launch Micafungin for Injection 50 mg/vial and 100 mg/vial

Company Snapshot